Christopher P. Lowe - 03 Jan 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
COO & Chief Financial Officer
Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Issuer symbol
QNCX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 16:05:49 UTC
Previous filing
16 Nov 2021
Next filing
04 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +125,000 $0.000000 125,000 03 Jan 2022 Common Stock 125,000 $13.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant.